Company Intelligence
Narval
Narval provides enterprise-grade artificial intelligence solutions, delivering specialized Synthetic Antibody Mimetic Proteins for novel first-in-class immunotherapeutics technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Zapopan, Americas
- Website
- narvalbio.com
- Founded
- 2024
- Stage
- Techstars Industries of the Future Accelerator
- Status
- Active
- Products
- 1
- Reports
- 4
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Narval is an Enterprise Software AI company based in Zapopan, Americas, founded in 2024.
Narval develops synthetic Antibody Mimetic Proteins for novel first-in-class immunotherapeutics.
What it builds
Synthetic Antibody Mimetic Proteins for novel first-in-class immunotherapeutics
Why It Matters
Narval provides enterprise-grade artificial intelligence solutions, delivering specialized Synthetic Antibody Mimetic Proteins for novel first-in-class immunotherapeutics technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Narval
Explore Narval by Narval. Verified AI product intelligence covering core capabilities, Enterprise Software use cases, technical architecture, and…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Narval
Industry
Products
Capabilities
- Synthetic Antibody Mimetic Proteins for novel first-in-class immunotherapeutics
Features
- Synthetic Antibody Mimetic Proteins for novel first-in-class immunotherapeutics
Country
Related companies
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Narval do?
Narval specializes in artificial intelligence, developing Synthetic Antibody Mimetic Proteins for novel first-in-class immunotherapeutics to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Narval based and when was it founded?
Narval is based in Americas and was founded in 2024.
What are the main products offered by Narval?
The flagship platform from Narval is Synthetic Antibody Mimetic Proteins for novel first-in-class immunotherapeutics, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Narval?
Narval primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.